According to NewAmsterdam Pharma Company's latest financial reports the company's current revenue (TTM) is HK$0.10 B. In 2023 the company made a revenue of HK$0.10 B a decrease over the revenue in the year 2022 that were of HK$0.85 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.